Related Experiment Video
Updated: Feb 19, 2026

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection
Published on: December 30, 2025
Hemodialysis for removal of dabigatran in a patient with gastric hemorrhage
Masahiro Kashiura1, Hiroshi Fujita2, Kazuhiro Sugiyama1
1Tertiary Emergency Medical Center Tokyo Metropolitan Bokutoh Hospital Tokyo Japan.
Case:
An 82-year-old man taking dabigatran was admitted with syncope. Computed tomography showed extravasation from the stomach. Laboratory data revealed renal insufficiency and prolonged activated partial thromboplastin time. The gastric endoscopy showed a gastric ulcer with an exposed vessel. However, an endoscopic hemostatic procedure failed to completely stop the bleeding. The patient experienced cardiac arrest from hypotensive shock. Spontaneous circulation returned after 5 min of resuscitation. After endoscopy, computed tomography showed a gastric perforation. For dabigatran removal, the patient underwent a 6-h hemodialysis session. Thrombin activity and thrombin-antithrombin complex increased during hemodialysis, while activated partial thromboplastin time decreased.
Outcome:
Good recovery was observed after dialysis and the following gastrectomy.
Conclusion:
Hemodialysis should be considered for dabigatran removal in cases of life-threatening hemorrhage. The thrombin-antithrombin complex may be useful for monitoring the plasma dabigatran level.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Prevention of Further Absorption of Poison
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Hemodialysis II: Procedure and Complications

